GLECKEL LOUIS MD has filed 4 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 100000 shares of ProPhase Labs, Inc. ($PRPH) on February 14, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2025 | ProPhase Labs, Inc. | $PRPH | GLECKEL LOUIS MD | Director | A | Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| March 17, 2024 | ProPhase Labs, Inc. | $PRPH | GLECKEL LOUIS MD | Director | A | Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | ProPhase Labs, Inc. | $PRPH | GLECKEL LOUIS MD | Director | A | Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 19, 2023 | ProPhase Labs, Inc. | $PRPH | GLECKEL LOUIS MD | Director | A | Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |